<DOC>
	<DOCNO>NCT01037582</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate safety , tolerability bioavailability ( explore absorption drug body ) NN9924 healthy male subject .</brief_summary>
	<brief_title>A Two Part Trial Investigating Safety NN9924 Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male subject good general health judge Investigator Body weight 65.095.0 kg ( inclusive ) Body Mass Index ( BMI ) 18.527.5 kg/m^2 ( inclusive ) Known suspect allergy trial product relate product Acute infection inflammation illness may confound result trial pose risk subject administer trial product , judged Investigator Presence clinically significant acute gastrointestinal symptom ( e.g . nausea , vomit , heartburn diarrhoea ) malabsorptive state ( celiac disease , lactose intolerance chronic pancreatitits ) , judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>